UBS AM’s Nuvalent NUVL Stock Holding History

UBS AM’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.5M	Sell	122,187 -2,368	-2%	-$241K	﹤0.01%	1085
2025 Q4	$12.5M	Buy	124,555 +59,138	+90%	+$5.83M	﹤0.01%	1035
2025 Q3	$5.66M	Sell	65,417 -104,122	-61%	-$8.23M	﹤0.01%	1313
2025 Q2	$12.9M	Buy	169,539 +19,598	+13%	+$1.43M	﹤0.01%	1234
2025 Q1	$10.6M	Buy	149,941 +12,123	+9%	+$948K	﹤0.01%	1195
2024 Q4	$10.8M	Sell	137,818 -3	-0%	-$280	﹤0.01%	1212
2024 Q3	$14.1M	Sell	137,821 -10,788	-7%	-$895K	﹤0.01%	1086
2024 Q2	$11.3M	Buy	148,609 +50,486	+51%	+$3.59M	﹤0.01%	1083
2024 Q1	$7.37M	Buy	98,123 +73,300	+295%	+$5.83M	﹤0.01%	1109
2023 Q4	$1.83M	Buy	24,823 +8,123	+49%	+$503K	﹤0.01%	1738
2023 Q3	$768K	Buy	16,700 +3,100	+23%	+$138K	﹤0.01%	2101
2023 Q2	$355K	Hold	13,600	–	–	﹤0.01%	2428
2023 Q1	$355K	Buy	13,600 +2,700	+25%	+$79.9K	﹤0.01%	2428
2022 Q4	$325K	Buy	+10,900	New	+$304K	﹤0.01%	2318

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS AM's NUVL Position: Q1 2026 in Review

UBS AM reduced its Nuvalent (NUVL) stake by 1.9% in Q1 2026, selling an estimated $241K and leaving 122,187 shares worth $12.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

UBS AM first reported a position in NUVL in Q4 2022 and has held it in 14 quarters since. The position peaked at $14.1M in Q3 2024. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

UBS AM held 122,187 shares of Nuvalent worth $12.5M as of Q1 2026.
UBS AM sold 2,368 Nuvalent shares in Q1 2026, an estimated $241K.
Nuvalent made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #1085 holding.
UBS AM first reported a position in Nuvalent in Q4 2022 and has held it in 14 quarters since.
UBS AM's Nuvalent position peaked at $14.1M in Q3 2024.
263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.